Kurtis E. Bachman, Ph.D.
Affiliations: | 2001 | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Genetics, Cell BiologyGoogle:
"Kurtis Bachman"Parents
Sign in to add mentor| Stephen B. Baylin | grad student | 2001 | Johns Hopkins | |
| (Epigenetic control of gene expression in human cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bhandari YR, Krishna V, Powers R, et al. (2023) Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America. 120: e2301536120 |
| Travers M, Brown SM, Dunworth M, et al. (2019) DFMO and 5-azacytidine increase M1 macrophages in the tumor microenvironment of murine ovarian cancer. Cancer Research |
| Stone ML, Chiappinelli KB, Li H, et al. (2018) Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic. Proceedings of the National Academy of Sciences of the United States of America |
| Stone ML, Chiappinelli KB, Li H, et al. (2017) Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. Proceedings of the National Academy of Sciences of the United States of America |
| Liu L, Shi H, Bleam MR, et al. (2014) Antitumor effects of dabrafenib, trametinib, and panitumumab as single agents and in combination in BRAF-mutant colorectal carcinoma (CRC) models. Journal of Clinical Oncology. 32: 3513-3513 |
| Hou W, Qin X, Zhu X, et al. (2013) Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. Oncology Reports. 30: 707-14 |
| van den Heuvel AP, Jing J, Wooster RF, et al. (2012) Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biology & Therapy. 13: 1185-94 |
| Higgins MJ, Jelovac D, Barnathan E, et al. (2012) Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3462-9 |
| Jing J, Greshock J, Holbrook JD, et al. (2012) Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212. Molecular Cancer Therapeutics. 11: 720-9 |
| Heiser LM, Sadanandam A, Kuo WL, et al. (2012) Subtype and pathway specific responses to anticancer compounds in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 2724-9 |